This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dinkova-Kostova, A. T. Articles by Talalay, P. Search for Related Content PubMed PubMed Citation Articles by Dinkova-Kostova, A. T. Articles by Talalay, P. Related Collections Clinical Intervention Clinical Intervention: Biomarkers Preclinical Intervention: In Vivo (Animals): Drugs, Nutritional Interventions, Mechanisms Preclinical Intervention: Biomarkers

Induction of the Phase 2 Response in Mouse and Human Skin by Sulforaphane-containing Broccoli Sprout Extracts

¹ Department of Pharmacology and Molecular Sciences, ² Division of Clinical Pharmacology, Department of Medicine, and ³ Department of Biological Chemistry, Johns Hopkins School of Medicine, Baltimore, Maryland

Requests for reprints: Paul Talalay, Department of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205. E-mail: ptalalay{at}jhmi.edu

The isothiocyanate sulforaphane was isolated from broccoli extracts in a bioactivity-guided fractionation as the principal and very potent inducer of cytoprotective phase 2 enzymes and subsequently shown to inhibit tumor development in animal models that involve various carcinogens and target organs. Because broccoli and broccoli sprouts are widely consumed, extracts obtained from them are viewed as convenient vehicles for sulforaphane delivery to humans. In relation to our current interest in devising strategies for protection against UV light–induced skin cancer, it was necessary to examine the safety and efficacy of topical application of sulforaphane-containing broccoli sprout extracts as single and multiple doses in both mice and humans. Topical application of an extract delivering 100 nmol sulforaphane/cm² increased the protein levels of NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione S-transferase A1, and heme oxygenase 1, three representative phase 2 enzymes, in mouse skin epidermis. Quantitative assessment of the activity of NQO1 24 h after dosing showed increases of 1.5- and 2.7-fold after application of single and multiple (thrice, every 24 h) doses, respectively. A dose-escalation safety study in healthy human subjects revealed no adverse reactions when doses as high as 340 nmol of sulforaphane in the form of broccoli sprout extracts were applied topically to the center of a 1-cm-diameter circle drawn on the volar forearm. A subsequent efficacy study showed that despite the interindividual differences in basal levels, the enzyme activity of NQO1 in homogenates of 3-mm full thickness skin punch biopsies increased in a dose-dependent manner, with maximum increases of 1.5- and 4.5-fold after application of 150 nmol doses, once or three times (at 24 h-intervals), respectively, thus providing direct evidence for induction of the phase 2 response in humans. (Cancer Epidemiol Biomarkers Prev 2007;16(4):847–51)

This article has been cited by other articles:

				P. Talalay, J. W. Fahey, Z. R. Healy, S. L. Wehage, A. L. Benedict, C. Min, and A. T. Dinkova-Kostova Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation PNAS, October 30, 2007; 104(44): 17500 - 17505. [Abstract] [Full Text] [PDF]

				M. L. Kerns, D. DePianto, A. T. Dinkova-Kostova, P. Talalay, and P. A. Coulombe Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex PNAS, September 4, 2007; 104(36): 14460 - 14465. [Abstract] [Full Text] [PDF]